AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 8,433.50
-95.50 (-1.12%)
Jun 19, 2026, 3:29 PM IST
AstraZeneca Pharma India Employees
AstraZeneca Pharma India had 600 employees as of March 31, 2026. The number of employees decreased by 202 or -25.19% compared to the previous year.
Employees
600
Change (1Y)
-202
Growth (1Y)
-25.19%
Revenue / Employee
37.93M INR
Profits / Employee
3.13M INR
Market Cap
210.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 600 | -202 | -25.19% |
| Mar 31, 2025 | 802 | -138 | -14.68% |
| Mar 31, 2024 | 940 | -7 | -0.74% |
| Mar 31, 2023 | 947 | -236 | -19.95% |
| Mar 31, 2022 | 1,183 | -100 | -7.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ipca Laboratories | 16,778 |
| Alembic Pharmaceuticals | 16,571 |
| Ajanta Pharma | 9,628 |
| Emcure Pharmaceuticals | 6,731 |
| Piramal Pharma | 5,476 |
| Gland Pharma | 4,351 |
| NATCO Pharma | 4,199 |
| Eris Lifesciences | 3,354 |
AstraZeneca Pharma India News
- 3 days ago - AstraZeneca Pharma India appoints Praveen K Mittal as Director - Corporate Affairs - Business Upturn
- 7 days ago - AstraZeneca Pharma India announces resignation of senior management personnel - Business Upturn
- 8 days ago - AstraZeneca gets CDSCO approval to sell Enhertu in India for first-line HER2-positive breast cancer treatment - Business Upturn
- 24 days ago - Why are AstraZeneca Pharma shares down over 4% today? Explained - Business Upturn
- 24 days ago - AstraZeneca Pharma India Quarterly report: Q4 2026 - Filings
- 24 days ago - AstraZeneca Pharma India reports 33% revenue growth for FY 2025-26 - Business Upturn
- 4 weeks ago - AstraZeneca Pharma India gets CDSCO nod for expanded use of Calquence in Mantle Cell Lymphoma Treatment - Business Upturn
- 4 weeks ago - AstraZeneca designates key managerial personnel for materiality determination - Business Upturn